Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.
Company profile
Ticker
CBBT
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Discount Dental Materials, Inc.
SEC CIK
Corporate docs
IRS number
261974399
CBBT stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
3 Sep 21
NT 10-K
Notice of late annual filing
1 Oct 19
8-K
Departure of Directors or Certain Officers
23 Jul 19
10-Q
2019 Q3
Quarterly report
20 May 19
NT 10-Q
Notice of late quarterly filing
16 May 19
DEF 14C
Information statement
22 Apr 19
8-K
Entry into a Material Definitive Agreement
5 Apr 19
PRE 14C
Preliminary information
5 Apr 19
10-Q
2019 Q2
Quarterly report
19 Feb 19
NT 10-Q
Notice of late quarterly filing
15 Feb 19
Latest ownership filings
SC 13G/A
EMA Financial, LLC
27 Jan 21
SC 13G/A
Cerebain Biotech Corp.
13 Feb 20
SC 13G
Cerebain Biotech Corp.
15 Feb 19
4
ERIC CLEMONS
25 Sep 18
4
Wesley D. Tate
25 Sep 18
4
ERIC CLEMONS
16 Jun 16
4
Wesley D. Tate
15 Jun 16
4
Wesley D. Tate
21 Sep 15
4
ERIC CLEMONS
18 Sep 15
SC 13D/A
Cerebain Biotech Corp.
16 Jul 15
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|